Impact of immunotherapy on survival and treatment patterns of patients with extensive-stage small cell lung cancer: a study using a Japanese nationwide database
Compared with conventional chemotherapy, ICI therapy was associated with increased overall survival in patients with ES-SCLC. However, clinical implementation of ICI therapy was delayed, particularly in older patients.
Authors
- Yasutaka Ihara (ORCID: https://orcid.org/0000-0003-2538-6328)
- Megumi Mizutani
- Naoyuki Nogami
- Naoto Okada (ORCID: https://orcid.org/0000-0003-2476-9191)
- Yuki Shimomura (ORCID: https://orcid.org/0009-0006-8474-602X)
- Shoichiro Yamamoto
Institutions
- Kobe University Hospital (JP)
- Ehime University Hospital (JP)
- Yamaguchi University Hospital (JP)
- Ehime University (JP)
- Osaka Metropolitan University (JP)
Publication Details
- Journal
- Future Oncology
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1080/14796694.2026.2623038
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00